Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2026

The meeting highlights were published. PRAC agrees on communication to inform healthcare professionals that cases of severe liver injury with hepatic failure have been reported in patients treated with the epilepsy medicine Ontozry.